Hoping to challenge Gilead Sciences, the leader in H.I.V. drugs, the pharmaceutical giants GlaxoSmithKline and Pfizer said Thursday that they would form a specialty company to research, develop and market treatments for H.I.V., the virus that causes AIDS.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/glaxo-and-pfizer-join-forces-develop-and-market-hiv-drugs
[2] http://admin.indiaenvironmentportal.org.in/category/author/natasha-singer
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/new-york-times-new-york
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/aids